Colombia — National Food and Drug Surveillance Institute
Tracked across 2 events · 13 articles · First seen Sep 01, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Colombia — National Food and Drug Surveillance Institute, Colombia's health regulatory agency, granted approval for TAVALISSE, fulfilling its role in evaluating and authorizing pharmaceutical products for the Colombian market.
Sep 01, 2026 · 7 articles
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Colombian regulator; approvals needed for product registration.
Sep 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Colombia — National Food and Drug Surveillance Institute live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard